Trial intelligence / Profile preview

Miniket: S-Ketamine for Postoperative Pain

NCT01022840Phase 3Completed

Sponsor
Medical University of Graz
Start
Feb 2009
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by Medical University of Graz. Primary endpoint: Postoperative opioid consumption at 1 year. Started Feb 2009; status: completed.

02

Drugs

esketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01022840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01022840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call